NYSE:RYNRayonier Stock Price, Forecast & News

Rayonier's stock was trading at $22.64 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, RYN shares have increased by 23.3% and is now trading at $27.92.
View which stocks have been most impacted by Coronavirus.

6 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Rayonier in the last year. There are currently 1 sell rating, 2 hold ratings and 3 buy ratings for the stock, resulting in a consensus recommendation of "Hold."
View analyst ratings for Rayonier.

Rayonier is scheduled to release its next quarterly earnings announcement on Wednesday, August 5th 2020.
View our earnings forecast for Rayonier.

Rayonier Inc. (NYSE:RYN) released its quarterly earnings results on Wednesday, April, 29th. The real estate investment trust reported $0.04 earnings per share for the quarter, missing the consensus estimate of $0.07 by $0.03. The real estate investment trust earned $259.10 million during the quarter, compared to analyst estimates of $166.06 million. Rayonier had a net margin of 7.74% and a return on equity of 2.25%. The business's revenue for the quarter was up 35.3% compared to the same quarter last year. During the same period in the prior year, the company earned $0.19 earnings per share.
View Rayonier's earnings history.

Rayonier declared a quarterly dividend on Monday, July 27th. Stockholders of record on Wednesday, September 16th will be paid a dividend of $0.27 per share on Wednesday, September 30th. This represents a $1.08 dividend on an annualized basis and a dividend yield of 3.87%. The ex-dividend date of this dividend is Tuesday, September 15th.
View Rayonier's dividend history.

Rayonier issued an update on its FY 2020 After-Hours earnings guidance on Wednesday, August, 5th. The company provided earnings per share guidance of 0.17-0.21 for the period, compared to the Thomson Reuters consensus estimate of $0.16.

6 Wall Street analysts have issued 1 year target prices for Rayonier's shares. Their forecasts range from $25.00 to $33.00. On average, they expect Rayonier's share price to reach $29.50 in the next twelve months. This suggests a possible upside of 5.7% from the stock's current price.
View analysts' price targets for Rayonier.

Media headlines about RYN stock have been trending neutral recently, according to InfoTrie Sentiment. InfoTrie identifies negative and positive news coverage by analyzing more than six thousand news and blog sources in real time. The firm ranks coverage of companies on a scale of negative five to five, with scores nearest to five being the most favorable. Rayonier earned a news impact score of 0.2 on InfoTrie's scale. They also gave news headlines about the real estate investment trust a news buzz of 0.0 out of 10, meaning that recent news coverage is extremely unlikely to have an impact on the stock's share price in the immediate future.
View the latest news about Rayonier.

Some companies that are related to Rayonier include American Tower (AMT), Public Storage (PSA), Welltower (WELL), Weyerhaeuser (WY), Ventas (VTR), HCP (HCP), Extra Space Storage (EXR), Medical Properties Trust (MPW), Host Hotels and Resorts (HST), Omega Healthcare Investors (OHI), CubeSmart (CUBE), Life Storage (LSI), Healthcare Realty Trust (HR), Sabra Health Care REIT (SBRA) and Potlatchdeltic (PCH).
View all competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Rayonier investors own include Energy Transfer LP Unit (ET), Bank of America (BAC), Weyerhaeuser (WY), AT&T (T), Enterprise Products Partners (EPD), Apollo Global Management (APO), Wells Fargo & Co (WFC), Ford Motor (F), Occidental Petroleum (OXY) and Pfizer (PFE).

Rayonier trades on the New York Stock Exchange (NYSE) under the ticker symbol "RYN."

Rayonier's stock is owned by many different institutional and retail investors. Top institutional shareholders include Confluence Investment Management LLC (2.42%), Marathon Asset Management LLP (0.96%), Principal Financial Group Inc. (0.45%), Russell Investments Group Ltd. (0.39%), Swiss National Bank (0.22%) and Gillespie Robinson & Grimm Inc. (0.14%). Company insiders that own Rayonier stock include Andrew G Wiltshire, April J Tice, D Clay Bretches, David L Nunes, Mark Mchugh and W Rhett Rogers.
View institutional ownership trends for Rayonier.

RYN stock was sold by a variety of institutional investors in the last quarter, including Marathon Asset Management LLP, Mackay Shields LLC, Confluence Investment Management LLC, UBS Group AG, Zeke Capital Advisors LLC, Hartford Financial Management Inc., Lantz Financial LLC, and Arizona State Retirement System.
View insider buying and selling activity for Rayonier.

RYN stock was bought by a variety of institutional investors in the last quarter, including Gillespie Robinson & Grimm Inc., Russell Investments Group Ltd., Principal Financial Group Inc., Timber Creek Capital Management LLC, Hollencrest Capital Management, Swiss National Bank, First Quadrant L P CA, and SG Americas Securities LLC. Company insiders that have bought Rayonier stock in the last two years include Andrew G Wiltshire, April J Tice, D Clay Bretches, David L Nunes, and W Rhett Rogers.
View insider buying and selling activity for Rayonier.

Shares of RYN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of RYN stock can currently be purchased for approximately $27.92.

Rayonier has a market capitalization of $3.61 billion and generates $711.60 million in revenue each year. The real estate investment trust earns $59.10 million in net income (profit) each year or $0.46 on an earnings per share basis. Rayonier employs 349 workers across the globe.

The official website for Rayonier is www.rayonier.com.

Rayonier's mailing address is 1 RAYONIER WAY, WILDLIGHT FL, 32097. The real estate investment trust can be reached via phone at 904-357-9100 or via email at [email protected]